The CCP Virus (coronavirus) pandemic has killed 1 million people across the world as of early Monday, Sept. 28, just 10 months after the disease first emerged in Wuhan, China, in December 2019 and spread over the globe.

Data from Worldometer website shows that the lethal virus claimed more than 1 million lives from 33.3 million recorded infections. Meanwhile, a total of 24.6 million victims have recovered from the disease.

Though the pandemic started in China, the United States has suffered the highest number of deaths with more than 209,000 fatalities from 7.3 million infections.

President Donald Trump’s administration has repeatedly accused the Chinese Communist Party (CCP) of holding back information about the virus as well as the risk of its human-to-human transmission, leading to the disease spreading widely.

The other worst-hit countries include Brazil with 141,700 deaths, India with 95,600 deaths, Mexico with 76,400 deaths and Britain with 42,000 deaths.

Europe is now facing the second wave of infections, with Paris, London, and Madrid all forced to introduce measures to slow the number of cases threatening to overload their hospitals.

The World Health Organization (WHO) warned on Friday that the CCP Virus-related deaths could surge to 2 million if countries around the world do not uniformly work to suppress the spread.

“One million is a terrible number and we need to reflect on that before we start considering a second million,” said Dr. Mike Ryan, executive director of the WHO’s health emergencies program.

“The real question is: Are we prepared, collectively, to do what it takes to avoid that number?” he said. 

“The time for action is now on every single aspect of this strategic approach,” Ryan said. “Not just test and trace, not just clinical care, not just social distancing, not just hygiene, not just masks, not just vaccines. Do it all. And unless we do it all, [2 million deaths] are not only imaginable but unfortunately and sadly very likely.” 

According to the WHO, nine vaccine candidates are currently in the last-stage clinical trials, with hopes some will be rolled out next year.